Lundin Law PC announces it is investigating claims against Globus
Medical, Inc. (“Globus” or the “Company”) (NYSE:GMED) concerning
possible violations of federal securities laws between February 26, 2014
and August 5, 2014. The investigation is related to allegations that
certain statements issued by Globus were false and misleading concerning
the Company’s financial performance.
To join this class action lawsuit, please contact Brian Lundin, Esquire,
of Lundin Law PC, at 888-713-1033, or via e-mail at brian@lundinlawpc.com.
The investigation will focus on whether the Company made misleading
statements and/or failed to disclose that: (a) Globus Medical’s
relationship with a significant distributor was deteriorating; (b) such
deterioration was negatively impacting Globus Medical’s financial
performance; and (c) as a result of the foregoing, defendants’
statements about the Company’s business and operations were false and
misleading. When the truth was revealed to the investing public, shares
dropped causing investors harm.
No class has been certified in the above action. Until a class is
certified, you are not considered represented by an attorney. You may
also choose to do nothing and be an absent class member.
Lundin Law PC was created by Brian Lundin, a securities litigator based
in Los Angeles.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151103007071/en/
Copyright Business Wire 2015